Company Overview and News

 
Zee Learn Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Zee Learn Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Zee Learn Limited - Press Release

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Zee Learn Limited - Outcome of Board Meeting

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Zee Learn Limited - Dividend

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
ICICI Bank, Tata Chem, Tata Coffee results

2018-05-04 thehindubusinessline
Saturday-Monday will see close to two dozen companies announcing their quarterly and full-year results for FY 2018. These are Avenue Supermarts, Balaxi Ventures, DIC India, JP Power and Jayant Agro (on Saturday); Intellect Design Arena (Sunday); and Filatex, Firstsource, Hinduja Ventures, ICICI Bank, INOX Leisure, Pfizer, Rane Holdings, Software Group, Shalby, Tata Chemicals, Tata Coffee, Tata Investment, Trident, Tube Investments, Vijaya Bank and Zee Learn (on Monday).

 
MT Educare: Open offer from Zee Learn begins

2018-05-02 thehindubusinessline
The open offer from Zee Learn, part of media baron Subash Chandra-led Essel Group, will open to shareholders of education services company MT Educare on Thursday. After acquiring 44.53 per cent of MT Educare’s promoter stake, Zee Learn has made a mandatory open offer to buy an additional 26 per cent stake at ₹72.76 apiece. The open offer will close on May 16. In the case of oversubscription, acceptance will be determined on proportionate basis.

 
Zee Learn Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011

2018-04-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Zee Learn Limited - Trading Window

2018-04-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Closing Bell: Sensex ends 74 pts higher but fails to hold 33K; Bharti Infratel up 5%

2018-03-20 moneycontrol
3:30 pm Market Closing: The market closed mildly higher amid volatility ahead of two-day US Federal Reserve meeting beginning later in the day.

 
Market Live: Sensex volatile ahead of US Fed meet; IOC falls for 5th day, ICICI dips

2018-03-20 moneycontrol
2:40 pm New Telecom Policy: Union Minister Manoj Sinha said the new telecom policy is almost ready and will be brought in the next session of Parliament after a Cabinet nod.

 
Market Live: Sensex holds morning gains ahead of US Fed meet; Cipla recovers

2018-03-20 moneycontrol
12:42 pm Market Update: The market continued to trade higher with the Sensex rising more than 100 points and was trading above the 33,000 levels. Investors looked for cues from the two-day US Federal Reserve meeting beginning later in the day.

 
Market Live: Sensex reclaims 33,000, up 100 pts ahead of US Fed meet

2018-03-20 moneycontrol
11:24 am Market Update: The market continued to trade higher with the BSE Sensex rising around 100 points amid volatility ahead of the US Fed's key policy meet that begins later in the day.

 
Market Live: Sensex at day#39;s high, Nifty above 10,100; IT stocks lead recovery

2018-03-20 moneycontrol
10:40 am Buzzing: Shares in India's Canara Bank tumbled more than 5 percent after the country's federal police filed charges against a former chairman of the state-run bank and others over allegations that the officials helped a company defraud the bank of about USD 10.5 million taken in loans over four years ago.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...